ArticlePDF Available

Primary Gallbladder Adenocarcinoma in a Cat

Authors:

Abstract and Figures

Background: Biliary tumors have low incidence in cats and are more common in elderly animals. Hepatobiliary tumors have different classifications and their etiology is difficult to interpret. In most cases, the diagnosis is only possible in advanced stages, which clouds the precursor factors. The late diagnosis is explained by the absence or specificity of clinical manifestations and laboratory changes. The majority of hepatobiliary neoplasms in cats are incidental findings in surgeries or necropsies. This study aimed to report clinical, laboratory, pathological and immunohistochemical results in a feline case of gall bladder adenocarcinoma.Case: A cat, male, neutered, mixed breed, 4 years, was admitted at a veterinary clinic with a history of polyuria / polydipsia, anorexia, apathy, jaundice and emesis for 60 days. The animal had been treated in another clinic with silymarin, famotidine and cyanocobalamin, and fed by esophageal tube based on the presumptive clinical diagnosis of cholangitis. The clinical examination revealed jaundice, abdominal pain, weight loss, enlargement of the liver and gallbladder and the presence of a structure in the epigastric region. Based on clinical signs, blood tests (complete blood count and liver enzymes), abdominal ultrasound and thoracic radiography were requested. In the exam results, eosinophilia, bilirubinemia and increased alkaline phosphatase, glutamic pyruvic transaminase and gamma glutamyl transferase were observed, in addition to the presence of icteric and hemolyzed serum. Ultrasound exam revealed thickened and dilated cystic and common ducts, large and thick gallbladder, bile with bile mud, hypoechogenic liver, thickening in the duodenal papilla and enlarged pancreatic and duodenal lymph nodes. There were no alterations in thoracic radiography. Based on the findings, the diagnosis of extrahepatic biliary obstruction was suggested. In celiotomy, dilated gallbladder with a thick blackened wall was observed. Bile puncture was performed for analysis, and total cholecystectomy and removal of obstructive content was performed. The patient suffered cardiorespiratory arrest after the procedure. A fragment of gallbladder and liver were sent to evaluation with histopathology and immunohistochemistry, and results were compatible with gallbladder adenocarcinoma.Discussion: Hepatobiliary neoplasms in cats are uncommon, apart from lymphoma. The incidence is higher in elderly cats and in males, which did not match the animal in this case. The clinical presentation of the condition is quite nonspecific, corroborating with other reports, in which changes are often only evident in advanced stages of the disease. Laboratory and imaging findings pointed to a biliary tree disorder, and cholangitis was suggested. However, the lack of clinical improvement and examination findings of exams lead to an exploratory laparotomy for better inspection of the organs and identification of possible causes. One of the differential diagnoses that should be considered in cats with extrahepatic biliary obstruction is gallbladder adenocarcinoma, especially in animals with an unsatisfactory response in clinical treatment. Tests such as histopathology and immunohistochemistry are essential for the definitive diagnosis of this neoplasm. Surgical resection is indicated in cases of malignant masses, providing longevity and better quality of life. Hypotension is a common complication in hepatobiliary surgeries, which can result in death.
Content may be subject to copyright.
Acta Scientiae Veterinariae, 2020. 48(Suppl 1): 540.
CASE REPORT
Pub. 540
ISSN 1679-9216
1
DOI: 10.22456/1679-9216.101267
Received: 24 March 2020 Accepted: 26 September 2020 Published: 25 October 2020
1Equalis, Programa de Pós-Graduação, Natal, RN, Brazil. 2 Hospital Veterinário Jerônimo Dix-Suit Rosado Maia, Universidade Federal Rural do Semi-
Árido (UFERSA), Mossoró, RN. 3Departamento de Medicina Veterinária, Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE, Brazil.
4Centro de Ciências da Saúde, Universidade de Fortaleza (UNIFOR), Fortaleza, CE, Brazil. 5Faculdade de Medicina Veterinária, Universidade Estadual
do Ceará (UECE), Fortaleza. CORRESPONDENCE: T.T. Diogenes [taianitorquato@gmail.com] & M.A. Rocha [mariana4981@hotmail.com]. Faculdade
de Medicina Veterinária, UECE. Av. Dr. Silas Munguba n. 1700. Campus Itaperi. CEP 60.740-903 Fortaleza, CE, Brazil.
Primary Gallbladder Adenocarcinoma in a Cat
Taiani Torquato Diogenes1, Mariana Araújo Rocha2, Keytyanne de Oliveira Sampaio3, Robério Gomes Olinda4,
Diana Celia Sousa Nunes Pinheiro5 & Reginaldo Pereira de Sousa-Filho5
ABSTRACT
Background: Biliary tumors have low incidence in cats and are more common in elderly animals. Hepatobiliary tumors
have different classifications and their etiology is difficult to interpret. In most cases, the diagnosis is only possible in ad-
vanced stages, which clouds the precursor factors. The late diagnosis is explained by the absence or specificity of clinical
manifestations and laboratory changes. The majority of hepatobiliary neoplasms in cats are incidental findings in surgeries
or necropsies. This study aimed to report clinical, laboratory, pathological and immunohistochemical results in a feline
case of gallbladder adenocarcinoma.
Case: 4-year-old male castrated mix breed cat was admitted at a veterinary clinic with a history of polyuria / polydipsia,
anorexia, apathy, jaundice and emesis for 60 days. The animal had been treated in another clinic with silymarin, famotidine
and cyanocobalamin, and fed by esophageal tube based on the presumptive clinical diagnosis of cholangitis. The clinical
examination revealed jaundice, abdominal pain, weight loss, enlargement of the liver and gallbladder and the presence of a
structure in the epigastric region. Based on clinical signs, blood tests (complete blood count and liver enzymes), abdominal
ultrasound and thoracic radiography were requested. In the exam results, eosinophilia, bilirubinemia and increased alkaline
phosphatase, glutamic pyruvic transaminase and gamma glutamyl transferase were observed, in addition to the presence
of icteric and hemolyzed serum. Ultrasound exam revealed thickened and dilated cystic and common ducts, large and
thick gallbladder, bile with bile mud, hypoechogenic liver, thickening in the duodenal papilla and enlarged pancreatic and
duodenal lymph nodes. There were no alterations in thoracic radiography. Based on the findings, the diagnosis of extrahe-
patic biliary obstruction was suggested. In celiotomy, dilated gallbladder with a thick blackened wall was observed. Bile
puncture was performed for analysis, and total cholecystectomy and removal of obstructive content was performed. The
patient suffered cardiorespiratory arrest after the procedure. A fragment of gallbladder and liver were sent to evaluation
with histopathology and immunohistochemistry, and results were compatible with gallbladder adenocarcinoma.
Discussion: Hepatobiliary neoplasms in cats are uncommon, apart from lymphoma. The incidence is higher in elderly cats
and in males, which did not match the animal in this case. The clinical presentation of the condition is quite nonspecific,
corroborating with other reports, in which changes are often only evident in advanced stages of the disease. Laboratory
and imaging findings pointed to a biliary tree disorder, and cholangitis was suggested. However, the lack of clinical im-
provement and examination findings of exams lead to an exploratory laparotomy for better inspection of the organs and
identification of possible causes. One of the differential diagnoses that should be considered in cats with extrahepatic
biliary obstruction is gallbladder adenocarcinoma, especially in animals with an unsatisfactory response in clinical treat-
ment. Tests such as histopathology and immunohistochemistry are essential for the definitive diagnosis of this neoplasm.
Surgical resection is indicated in cases of malignant masses, providing longevity and better quality of life. Hypotension
is a common complication in hepatobiliary surgeries, which can result in death.
Keywords: feline, immunohistochemical, liver, neoplasm, surgery.
2
T.T. Diogenes, M.A. Rocha, K.O. Sampaio, et al. 2020. Primary Gallbladder Adenocarcinoma in a Cat.
Acta Scientiae Veterinariae. 48(Suppl 1): 540.
INTRODUCTION
Primary gallbladder neoplasms are rare in cats,
in which incidence values vary from 1 to 3% among di-
fferent types [11]. These conditions are more common
in elderly animals and breed-related predispositions
have not been reported [1].
Hepatobiliary neoplasms are classified as
hepatocellular adenomas, hepatocellular adenocarci-
nomas, cholangiocellular adenomas, cholangiocellular
adenocarcinomas or mesenchymal tumors. The cho-
langiocellular adenocarcinomas include intrahepatic
bile duct adenocarcinomas, extrahepatic bile duct
adenocarcinomas and gallbladder carcinomas [3].
The etiologies of gallbladder tumors are hard to
interpret. In most cases, diagnosis is confirmed only in
advance stages of the disease, which hinders the identi-
fication of precursor lesions [7]. Late diagnosis may be
explained by the clinical presentation that is absent in
50% of cases and is composed by nonspecific signs, such
as inappetence, weight loss, lethargy and emesis [6].
Laboratory alterations, such as the increased
levels of serum liver enzymes are also unspecific [1].
Hence, half the cases of hepatobiliary tumors in cats
are incidental findings of surgeries or necropsies [4].
This study aimed to report clinical, laborato-
rial, pathological and immunohistochemical findings
in a case of gallbladder adenocarcinoma in a cat.
CASE
A 4-year-old male castrated mix breed cat was
admitted at a veterinary clinic for consultation. Accor-
ding to the owner, the individual presented a history
of apathy, polyuria/polydipsia, anorexia, emesis and
jaundice for 60 days. Based on a previous diagnosis of
cholangitis in another clinic, the individual was being
treated orally for 40 days with Silymarin1 [40 mg/kg,
twice a day BID], Famotidine2 [1 mg/kg, once a day
- SID], and with Cyanocobalamin3 [250 µg, via sub-
cutaneous injections every 7 days]. Patient was being
fed through an esophageal tube with hypercaloric pasty
feed for 30 days. In the clinical examination, emacia-
tion was observed with a body score of 4 (1-9 scale).
In addition, the individual presented jaundice in skin
and mucosa, hepatomegaly, abdominal pain and a mass
was identified in the epigastric region. In view of the
situation, some tests were requested, such as complete
blood count, biochemical enzyme activity (direct-
-bilirubin, free-bilirubin, indirect-bilirubin, Alkaline
Phosphatase - AP, Glutamic Pyruvic Transaminase
- GPT and Gamma-Glutamyl Transferase - GGT),
total abdominal ultrasound and thoracic radiography.
Leukogram results demonstrated intense eo-
sinophilia (2.624 cells/µL - reference: 0-1,500 cells/
µL/L). Serum biochemical profile presented elevated
levels of bilirubin (Direct bilirubin 11.4 mg/dL - re-
ference: 0.30 mg/dL; Indirect bilirubin 4.6 mg/dL
- reference: 0.0-0.5 mg/dL) liver enzymes (FA 255
mg/dL - reference: 25.0-93.0 mg/dL; TGP 527 mg/dL
- reference: 6.0-83.00 mg/dL; GGT 40.00 mg/dL - refe-
rence: 1.3-5.10 mg/dL), icteric and hemolyzed serum.
In abdominal ultrasonography, the liver pre-
sented reduced and gross echogenicity with no eviden-
ce of nodules or cysts. Gallbladder presented severely
thick echogenic walls (0.35 cm), anechoic bile with
hypoechoic content in the lowest part (biliary mud).
Cystic and common ducts were dilated (0.46 cm and
0.29 cm in diameter, respectively) and thick (0.09 cm
in both). Duodenum was also thick in the duodenal
papilla (0.30 cm) and pancreatic parenchyma was sli-
ghtly hypoechoic. Lymphadenomegaly was observed
in pancreatic and duodenal lymph nodes. Thoracic
radiography did not present alterations.
Considering the case and the unsatisfactory the-
rapeutic response, a possible diagnosis of extrahepatic
biliary obstruction was considered. Hence, a surgical
approach was suggested to perform a bilioenteric bypass.
Maintenance fluid therapy was recommended, and pain
was managed using Meloxicam4 [0.05 mg/kg, SC, SID]
for 3 days. The animal was submitted to surgery, in
which pre-anesthesia consisted of Methadone5 [0.3 mg/
kg, SC] and Dexmedetomidine6 (3 m/kg, SC). Isoflurane
was used for induction via mask and in maintenance at
2%. In the celiotomy, gallbladder was severely dilated
(Figure 1) and manual decompression was not possible.
In addition, the left liver duct, cystic duct and common
bile duct were ingurgitated. Gallbladder walls were
thick and dark. Hyperemia was observed in proximal
duodenal walls, omentum and peripancreatic fat, in
addition to lymphadenomegaly. Based on these findin-
gs, total cholecystectomy was performed. At the end of
surgery, a severe hypotension occurred, which resulted
in cardiorespiratory arrest. Resuscitation protocol was
performed with no success. A bile sample was collected
for cytology and bacterial culture. The excised gallblad-
der and a liver fragment were sent for histopathological
analysis. Bacterial culture was negative and cytology
3
T.T. Diogenes, M.A. Rocha, K.O. Sampaio, et al. 2020. Primary Gallbladder Adenocarcinoma in a Cat.
Acta Scientiae Veterinariae. 48(Suppl 1): 540.
results demonstrated squamous epithelial cells, neutro-
phils, macrophages and amorphous acellular material
with no evidence of bacteria or parasite eggs.
In histopathological examination, marked
proliferation of unencapsulated carcinoma epithelial
cells which infiltrated the mucosa and submucosa of
the gallbladder was observed. Neoplastic cells formed
irregular acini and papillary structures, which were
sustained by abundant fibrovascular stroma (marked
desmoplasia) [Figure 2A] . Multifocal intramural in-
flammatory infiltrate of neutrophils and eosinophils
was observed. Tumoral clots were seen in lymph and
blood vessels, in addition to necrotizing vasculitis
and fibrin thrombi in submucosal vessels. In the liver
fragment adjacent to the gallbladder, discrete fibrosis
and marked proliferation of periportal biliary ducts
was observed. In addition, a fine diffuse hepatocellular
vacuolization was identified.
According to the histopathological findings,
gallbladder adenocarcinoma was diagnosed. Samples
from these tissues were submitted to immunohistoche-
mical analysis, in which four biomarkers were used
in the peroxidase streptavidin-biotin technique with
the monoclonal antibodies Anti-Hepatocyte Specific
Antigen (Clone OCH1E5)7, Anti-CK Pan (Clone AE-
1AE3)8, Anti-CK7 (Clone OV-TL12/30)9 and CK20
(Clone Ks20.8)9. Immune expressions for CK Pan and
CK7 were observed, which confirmed the diagnosis
(Figure 2B,D) [Figure 2C].
DISCUSSION
Hepatobiliary neoplasia in cats is relatively un-
common with the exception of lymphomas [9]. A study
conducted by Patnaik [10], demonstrated that among
hepatobiliary tumors in cats, those of epithelial origin
and biliary system were most frequent, unlike humans
and dogs, in which liver neoplasia are more common.
Primary hepatobiliary tumors occur more fre-
quently in older and male individuals with average age
between nine and ten years [12]. However, the animal
in this case was much younger (4-year-old).
Clinical presentation presented by the cat in
this report consisted of apathy, anorexia and emesis,
which are unspecific. This finding corroborates with
[9] that reported these signs in hepatobiliary cases. Ac-
cording to Liptak et al. [6], only 50% of hepatobiliary
neoplasia cases in cats present clinical manifestations,
which are nonspecific and mostly identified in advan-
ced stages of the disease. Other clinical manifestations
include weight loss, jaundice, hepatomegaly, polyuria
and polydipsia [4,12].
The main biochemical alterations that were
identified in this case are unspecific for the tumor and
could occur in several conditions affecting liver and
biliary tree, including increased liver transaminases
and bilirubin [9]. Other expected laboratory findings
include neutrophilia and chronic anemia, which were
not observed in this report [1].
Clinical and laboratory alterations suggested
the initial diagnosis of cholangitis. However, the lack
of improvement after the clinical treatment and the
ultrasonographic findings suggestive of obstructive
condition, especially due to the dilation of common
and cystic ducts led to the extrahepatic biliary duct
obstruction diagnosis [2]. In addition, the presence of
biliary mud suggests cholestasis, which is considered
a significant finding in cats [4].
This condition may occur as a consequence of
chronic cholangitis, pancreatitis, gallstones, parasite
infestation and neoplasms [9]. Hence, all of these
conditions are considered as differential diagnoses of
gallbladder adenocarcinoma. Surgical exploration for
biliary decompression and inspection of liver and other
organs is recommended when the cause is not iden-
tified or in the absence of clinical improvement after
the treatment is initiated [2], which was the procedure
adopted in this case.
Neoplasm was demonstrated by the malignant
epithelial cell infiltrate in mucosa and submucosa of the
gallbladder. These cells presented immune expression
by CK7, which marks ductal, glandular, superficial
squamous and transition epitheliums, and by CK Pan,
which is a specific antigen marker of filaments of
epithelial cells that characterizes adenocarcinoma [5].
Surgical resection is indicated to provide
better duration and quality of life for the animal [12].
Chemotherapy does not present adequate results in the
treatment of primary hepatobiliary tumors [1]. During
surgery, the occurrence of hypotension is common in
cat anesthesia during procedures involving gallbladder
and biliary tree, which can result in death [8] as occur-
red in this case. A mechanism that may affect muscle
tonus in these patients is the presence of increased
bilirubin concentrations in blood. In addition, a possi-
ble increased liberation of nitric oxide associated with
obstructive jaundice have been reported in dogs [8].
4
T.T. Diogenes, M.A. Rocha, K.O. Sampaio, et al. 2020. Primary Gallbladder Adenocarcinoma in a Cat.
Acta Scientiae Veterinariae. 48(Suppl 1): 540.
Prognosis for malignant hepatobiliary neopla-
sia is unfavorable with elevated metastasis rates [3],
which were not observed in this case. However, the
possibility was clear, considering the tumoral clots
identified in histopathological analysis.
The gallbladder adenocarcinoma should be
considered as a differential diagnosis for extrahepatic
biliary obstruction in cats, especially in cases that are
unresponsive to clinical treatment. Histopathology and
immunohistochemistry are key tests to confirm the
presence of this neoplasia. Despite the risk of death
during surgery, the indicated treatment is surgical
resection with the aim to promote better quality of life
for the animal.
MANUFACTURERS
1Takeda Pharma Ltda. Jaguariúna, SP, Brazil.
2Aché Laboratórios Farmacêuticos S.A. Guarulhos, SP, Brazil.
3Laboratório Bravet Ltda. Rio de Janeiro, RJ, Brazil.
4Ouro Fino Saúde Animal Ltda. Cravinhos, SP, Brazil.
5Cristália Produtos Químicos Farmacêuticos Ltda. Itapira, SP, Brazil.
6Zoetis Inc. Parsippany, NJ, USA.
Figure 1. Gallbladder carcinoma in a cat. Marked dilation and thickening
of gallbladder walls.
Figure 2. Gallbladder carcinoma in a cat. A- Marked proliferation of carcinoma cells with acini-like structures. Cell morphology range from polygonal
to cuboidal with scarce to moderate eosinophilic cytoplasm. Nuclei are round to oval with vacuolated chromatin and evident nucleoli [H.E.; Obj. 20x].
B- Intense cytoplasmatic immune marking of epithelial cells for CK Pan [Obj. 10x]. C- Moderate cytoplasmatic immune marking of epithelial cells for
CK7 [Obj. 40x]. D- Intense cytoplasmatic immune marking of epithelial cells for CK Pan [Obj. 20x].
5
T.T. Diogenes, M.A. Rocha, K.O. Sampaio, et al. 2020. Primary Gallbladder Adenocarcinoma in a Cat.
Acta Scientiae Veterinariae. 48(Suppl 1): 540.
CR540
http://seer.ufrgs.br/ActaScientiaeVeterinariae
7Abcam Plc. Cambridge, RU, UK.
8Thermo Fisher Scientific Inc. Carlsbad, CA, USA.
9Dako North America Inc. Carpinteria, CA, USA.
Declaration of interest. The authors report no conflicts of
interest. The authors alone are responsible for the content and
writing of paper.
REFERENCES
1 Balkman C. 2009. Hepatobiliary neoplasia in dogs and cats. Veterinary Clinics of North America: Small Animal
Practice. 39(3): 617-625.
2 Center S.A. 2009. Diseases of the gallbladder and biliary tree. Veterinary Clinics of North America: Small Animal
Practice. 39(3): 543-598.
3 Cullen J.M. 2017. Tumors of the Liver and Gallbladder. In: Meuten D.J. (Ed). Tumors of Domestic Animals. 5th edn.
Ames: John Wiley & Sons Inc., pp.602-631.
4 Harran N., D’Anjou M.A., Dunn M. & Beauchamp G. 2011. Gallbladder sludge on ultrasound is predictive of
increased liver enzymes and total bilirubin in cats. The Canadian Veterinary Journal. 52(9): 999-1003.
5 Hornick J.L., Lauwers G.Y. & Odze R.D. 2005. Immunohistochemistry Can Help Distinguish Metastatic Pancre-
atic Adenocarcinomas from Bile Duct Adenomas and Hamartomas of the Liver. The American Journal of Surgical
Pathology. 29(3): 381-389.
6 Liptaik J.M., Dernell W.S. & Withrow S.J. 2004. Liver tumors in cats and dogs. Compendium on Continuing Educa-
tion for the Practising Veterinarian. 26(9): 50-56.
7 Meyer A., Jukemura J. & Penteado S. 2011. Tumores e pólipos de vesícula biliar. In: Zaterka S. & Eisig J.M. (Eds).
Tratado de Gastroenterologia da Graduação à Pós-Graduação. São Paulo: Atheneu, pp.877-882.
8 Monticelli P., Stathoupolou T.R., Lee K. & Adami C. 2017. Life-threatening perianaesthetic complications in five
cats undergoing biliary tract surgery: case series and literature review. Journal of Feline Medicine and Surgery. 19(6):
717-722.
9 Otte C.M., Penning L.C. & Rothuizen J. 2017. Feline biliary tree and gallbladder disease: aetiology, diagnosis and
treatment. Journal of Feline Medicine and Surgery. 19(5): 514-528.
10 Patnaik A.K. 1992. A morphologic and immunocytochemical study of hepatic neoplasms in cats. Veterinary Pa-
thology. 29(5): 405-415.
11 Patnaik A.K., Lieberman P.H., Erlandson R.A. & Antonescu C. 2005. Hepatobiliary neuroendocrine carcinoma in cats:
a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases. Veterinary Pathology. 42(3): 331-337.
12 Wypj J., Fan T.M. & Lorimier L.P. 2006. Primary hepatic and biliary tract tumors in dogs and cats: an overview.
Veterinary Medicine. 101(6): 384-394.
... In cats, neoplasms originating in bile duct cells occur more frequently than those originating in hepatocytes, and extrahepatic bile duct obstruction is a differential for gallbladder adenocarcinoma, especially in cases in which there has been no response to clinical treatment (2,10). There are reports of several animal species affected by adenomas and carcinomas of the biliary tract, such as cats (5,10,19,22), dogs (2,14,21), cattle (13,16), bears (20), and African lions (25). ...
... In cats, neoplasms originating in bile duct cells occur more frequently than those originating in hepatocytes, and extrahepatic bile duct obstruction is a differential for gallbladder adenocarcinoma, especially in cases in which there has been no response to clinical treatment (2,10). There are reports of several animal species affected by adenomas and carcinomas of the biliary tract, such as cats (5,10,19,22), dogs (2,14,21), cattle (13,16), bears (20), and African lions (25). ...
... In many cases, the diagnosis is late due to the presentation of nonspecific clinical signs. The most common signs are loss of appetite and weight, lethargy, and vomiting, in addition to jaundice, which is an important manifestation of biliary diseases (10). Blood count and abdominal ultrasound serve as screening tests for diseases of the hepatobiliary system. ...
Article
Biliary neoplasms are uncommon in cats and affect older animals. A 12-year-old female crossbreed cat showed prostration, lethargy, apathy, and severe jaundice. Ultrasonography showed distention of the gallbladder associated with severe obstruction of the bile ducts with thickening of the biliary wall, forming amorphous masses of irregular contour and heterogeneous appearance directed to the lumen measuring up to 2 cm. Necropsy showed a gallbladder with a yellowish and soft nodule measuring 3 × 3 cm, compressing the extrahepatic bile duct, occluding the passage of bile. There were also firm, yellowish multifocal to coalescing nodules in the liver, ranging from 0.5 to 1 cm, affecting 10% of the organ, in addition to lungs with firm, yellowish multifocal nodules ranging from 0.2 to 0.5 cm, affecting 20% of the organ. Histologically, gallbladder and bile ducts had malignant epithelial neoplastic proliferation, which was organized into multiple papillary and ductal projections, separated by moderate fibrovascular stroma compatible with gallbladder adenocarcinoma. The liver and lungs also contained neoplastic structures with a ductal appearance and papilliform projections identical to those observed in the gallbladder. The immunohistochemical examination (IHC) showed intense positive staining of epithelial neoplastic cells for pan-cytokeratin (AE1/AE3) and no staining for vimentin (Clone V9). The diagnosis of gallbladder adenocarcinoma with metastasis in the liver and lungs was established based on the clinical, macroscopic, histopathological, and immunohistochemical findings.
Article
Ultrasonography is the most commonly used diagnostic imaging tool for gallbladder disease in veterinary medicine. Primary gallbladder neoplasia is an uncommon finding with variable prognosis for which no studies have been published describing their ultrasonographic appearance and diagnosis. This retrospective, multicenter, case series study examines the ultrasonographic appearance of gallbladder neoplasia with histologically or cytologically confirmed diagnoses. A total of 14 dogs and 1 cat were analyzed. All discrete masses were sessile in shape and varied in size, echogenicity, location, and gallbladder wall thickening. All studies with images showing Doppler interrogation exhibited vascularity. Cholecystoliths were an uncommon finding, being present in only one case in this study, unlike in humans. The final diagnosis of the gallbladder neoplasia was neuroendocrine carcinoma (8), leiomyoma (3), lymphoma (1), gastrointestinal stromal tumor (1), extrahepatic cholangiocellular carcinoma (1), and adenoma (1). Findings from this study indicate that primary gallbladder neoplasms have variable sonographic appearances and cytologic and histologic diagnoses.
Article
There is scant literature on primary nonhematopoietic malignant liver tumors (PMLT) in cats. In this retrospective study, medical data of 40 cats diagnosed with PMLT were reviewed over a period of 22 years (2000‐2021). The most frequent epithelial tumors were hepatocellular (42.5%) and bile duct carcinomas (32.5%), only six (15%) cats had mesenchymal tumors. The median age was 13 years and clinical signs commonly included ano‐/hyporexia (62.5%), apathy/lethargy (52.5%), weight loss (42.5%) and vomiting (35%). At initial diagnosis, metastases were confirmed in 1 (2.5%) and suspected in three (7.5%) cats. Massive was the most frequent morphology (75%). Most intrahepatic tumors were left‐sided (54.2%) with the left medial lobe being primarily affected (25%). Extrahepatic tumors were rare (5%). In 34 (85%) cats, liver lobectomy was performed (surgery group), four (10%) were treated palliatively (non‐surgery group), and two (5%) received no treatment. Intraoperative complications occurred in 11.8% with four (15.4%) postoperative deaths. Recurrence was detected in 28.6% at a median of 151 days (range, 79‐684 days), while postoperative metastases were suspected in 21.4% at a median of 186 days (range, 79‐479 days). The median survival time (MST) was significantly longer in cats of the surgery group (375 days) than in the non‐surgery group (16 days) (P = 0.002). MST was 868 days for hepatocellular compared to 270 days for bile duct carcinomas (P = 0.06). In summary, liver lobectomy is associated with prolonged survival times and good prognosis in cats with hepatocellular, and an acceptable prognosis in cats with bile duct carcinoma.
Article
Full-text available
The purposes of this retrospective study were to assess the prevalence of gallbladder sludge (GBS) in a population of cats presented for abdominal ultrasound in a teaching hospital and to determine its association with increased serum alanine aminotransferase (ALT), alkaline phosphatase (ALP), and total bilirubin (TB). Gallbladder sludge was detected in 152 (14%) of the cats undergoing abdominal ultrasound between 2004 and 2008. This population was compared to a control group of 32 cats without GBS. Alanine aminotransferase, ALP, and TB mean values were significantly higher in cats with GBS than in controls (P ≤ 0.0005) and odds for increased values in cats with GBS were 4.2 [95% confidence interval (CI): 1.6 to 11.0], 9.5 (95% CI: 2.2 to 41.7), and 4.1 (95% CI: 1.5 to 11.5), respectively (P ≤ 0.007). In conclusion, GBS is an uncommon ultrasonographic finding in cats that is predictive of increased liver enzymes and TB. More studies are needed to establish potential links between GBS and hepatobiliary disease in cats.
Article
Practical relevance Diseases of the biliary tree and gallbladder are more common in cats than diseases of the liver parenchyma. The parenchyma is usually affected secondarily to systemic illnesses, while the biliary system is the prime target for infectious agents (eg, bacteria and flukes) and non-infectious conditions (eg, neoplasia and cysts). Clinical approaches Cats with biliary disease are evaluated because of common feline clinical signs such as anorexia, nausea, vomiting and lethargy. Icterus may or may not be obvious. Biopsies for histological evaluation, and bile aspirates for culture and cytological evaluation are helpful diagnostically. Antibiotics and immunosuppressive drugs have been used successfully. Hepatosupportive drugs may help in liquefying thick bile and protecting hepatic tissue from damage. Ultrasound is a noninvasive diagnostic tool that may help in identifying dilated bile ducts, liver cysts and choleliths. It is also used to guide percutaneous bile aspiration. Audience This review, written for all veterinarians who treat cats, describes the various conditions that can affect the feline biliary tree and gallbladder. Treatment options are discussed, and brief summaries provided of surgical techniques and diagnostic approaches. Evidence base The veterinary literature pertaining to feline biliary disease is comprehensively reviewed. When appropriate, data on dogs and humans has been included to provide background information. Based on the available literature, more research into feline biliary diseases is needed.
Article
Hepatobiliary tumors are uncommon in dogs and cats. They generally occur in older animals with nonspecific clinical signs, usually relating to the gastrointestinal tract. Liver enzyme concentrations are commonly elevated. Early detection for massive-type lesions may allow for surgical resection and prolonged survival especially for hepatocellular carcinomas. Chemotherapy, in general, is not effective for primary liver tumors.
Article
Most disorders of the biliary system are associated with increased activity of parenchymal transaminases (alanine aminotransferase, aspartate aminotransferase) and cholestatic enzymes (alkaline phosphatase and gamma glutamyl transferase) with or without hyperbilirubinemia or jaundice. While parenchymal liver disease is most common in the dog, inflammatory disorders involving the small- and medium-sized bile ducts and zone 1 (periportal) hepatocytes predominate in the cat. Historically, the incidence of disorders restricted to the gallbladder is low in both species; however, with routine diagnostic use of abdominal ultrasonography, the incidence of gallbladder mucoceles and cholelithiasis has increased. Extrahepatic bile duct obstruction is a well-recognized syndrome because of its association with pancreatitis and obvious jaundice. Less common disorders of the biliary system include a cadre of diverse conditions, including necroinflammatory processes, cholelithiasis, malformations, neoplasia, and an emerging syndrome of gallblader dysmotility.
Article
A retrospective study was done of 47 neoplasms of the hepatic and biliary systems from 47 cats brought to The Animal Medical Center over a period of 10 years (1980 to 1989). Histologic examination of specimens taken at necropsy revealed that 87% (41/47) of the hepatic neoplasms were epithelial and 13% (6/47) were nonepithelial. Of the epithelial tumors, 25/47 (53%) were of intrahepatic bile duct origin, 9/47 (19%) were of hepatocellular origin, 5/47 (11%) involved the extrahepatic bile ducts, and 2/47 (4%) were adenocarcinomas of the gall bladder. Of the nonepithelial neoplasms, hemangiosarcomas were more common, 5/47 (11%), than leiomyosarcomas, 1/47 (2%). Multiple liver lobes were involved in 21/34 (62%) of the epithelial and all six of the nonepithelial intrahepatic neoplasms. Most of the bile duct adenocarcinomas (6/9) were predominantly characterized by acinar structures with mucin production, diffuse necrosis, and little desmoplasia. The hepatocellular carcinomas were characterized by three patterns-trabecular (five tumors), pseudoglandular pattern (two tumors), and anaplastic (one tumor). The hepatic carcinoid was characterized by various-sized groups of acinar and rosettelike structures, some with lumens, separated by thin fibrovascular stroma. The extrahepatic bile duct adenocarcinomas (4/4) were acinopapillary with moderate desmosplasia, whereas the adenocarcinomas of the gall bladder had elongated tubular structures lined by anaplastic cells and a severe desmoplastic reaction. The neuroendocrine carcinoma of the extrahepatic bile duct, the hemangiosarcomas, and the leiomyosarcoma had morphologic features characteristic of these neoplasms. Two of the 16 (13%) bile duct adenomas had anaplastic and precancerous changes. Residual benign components were seen in 10/15 (67%) of the biliary adenocarcinomas, 4/9 (44%) of the intrahepatic bile duct adenocarcinomas, and all of the extrahepatic bile duct adenocarcinomas and gall bladder adenocarcinomas. Results of immunohistochemical studies of the biliary neoplasms were similar to those described in studies of biliary neoplasms in human beings. Results of this study revealed that the frequency of different types of hepatic neoplasms in cats varied from that seen in dogs and human beings, but the morphologic features were comparable.
Article
Not uncommonly, bile duct adenomas (BDAs) and hamartomas (BDHs) of the liver may be difficult to distinguish from metastatic well-differentiated ductal adenocarcinoma of the pancreas. However, this distinction is critical for proper staging and patient management. The primary purpose of this study was to determine if a panel of immunohistochemical stains can help distinguish BDA or BDH from metastatic pancreatic adenocarcinoma in the liver. Routinely processed tissue sections from 25 BDA, 10 BDH, 25 metastatic pancreatic adenocarcinomas to the liver and 6 cases each of metastatic colorectal, breast, and lung adenocarcinomas were immunohistochemically stained for CK7, CK8/CK18, CK19, CK20, p53, p63, TAG-72, monoclonal CEA (mCEA), polyclonal CEA (pCEA), HER-2/neu, AMACR (alpha-methylacyl-CoA racemase), Dpc4 (Smad4), and mesothelin. The slides were evaluated in a blinded fashion, and the results were compared between the benign and malignant lesions. Significantly more (P < 0.05) metastatic pancreatic adenocarcinomas were positive for CK20 (76%), p53 (60%), TAG-72 (88%), mCEA (92%), HER2/neu (40%), and mesothelin (64%) and showed loss of Dpc4 (44%), in comparison to BDA (CK20, 40%; p53, 0%; TAG-72, 0%; mCEA, 0%; HER2/neu, 12%; mesothelin, 0%; loss of Dpc4, 0%) or BDH (CK20, 10%; p53, 0%; TAG-72, 0%; mCEA, 10%; HER2/neu, 0%; mesothelin, 0%; loss of Dpc4, 0%). Of these antibodies, p53, TAG-72, mCEA, loss of Dpc4, and mesothelin had the highest specificity for pancreatic adenocarcinoma, with mCEA having the highest sensitivity (92%). No significant differences were observed in the degree of CK7, CK8/CK18, CK19, or pCEA expression between the three types of lesions. Although none of the BDA or BDH was positive for either p63 or AMACR, two of the metastatic pancreatic adenocarcinomas (8%) were positive for each of these peptides (P > 0.05). For nonpancreatic adenocarcinomas, mCEA showed a reasonably high sensitivity and 100% specificity in the differential diagnosis versus BDA. Immunohistochemical expression of p53, TAG-72, mCEA, mesothelin, and loss of Dpc4 can help distinguish metastatic pancreatic adenocarcinoma in the liver from BDA or BDH. Although p63 and AMACR are also specific for pancreatic adenocarcinoma, their low sensitivity limits their use in clinical practice.
Liver tumors in cats and dogs. Compendium on Continuing Education for the Practising Veterinarian
  • J M Liptaik
  • W S Dernell
  • S J Withrow
Liptaik J.M., Dernell W.S. & Withrow S.J. 2004. Liver tumors in cats and dogs. Compendium on Continuing Education for the Practising Veterinarian. 26(9): 50-56.
Tratado de Gastroenterologia da Graduação à Pós-Graduação
  • A Meyer
  • J Jukemura
  • S Penteado
Meyer A., Jukemura J. & Penteado S. 2011. Tumores e pólipos de vesícula biliar. In: Zaterka S. & Eisig J.M. (Eds). Tratado de Gastroenterologia da Graduação à Pós-Graduação. São Paulo: Atheneu, pp.877-882.
Life-threatening perianaesthetic complications in five cats undergoing biliary tract surgery: case series and literature review
  • P Monticelli
  • T R Stathoupolou
  • K Lee
  • C Adami
Monticelli P., Stathoupolou T.R., Lee K. & Adami C. 2017. Life-threatening perianaesthetic complications in five cats undergoing biliary tract surgery: case series and literature review. Journal of Feline Medicine and Surgery. 19(6): 717-722.